Orlando Rivera, DPM
Foot & Ankle Surgery · Houston, TXNPI 1720016827
Payments from drug & device makers
Across 60 payments — averaging $6393.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$368K
- Skye Orthobiologics LLC$12K
- Treace Medical Concepts, Inc.$1K
- In2bones USA, LLC$1K
- Paratek Pharmaceuticals, Inc.$217
- AbbVie$182
- plus $689 from 15 others
What the payments were for
- Speaking & faculty fees$1,0000%
- Travel & lodging$5880%
- Food & beverage$1,5800%
- Education$780%
- Other$380,38999%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 5 | $368,189 |
| Skye Orthobiologics LLC | 1 | $12,200 |
| Treace Medical Concepts, Inc. | 18 | $1,159 |
| In2bones USA, LLC | 1 | $1,000 |
| Paratek Pharmaceuticals, Inc. | 10 | $217 |
| AbbVie(2 entities) | 4 | $182 |
| Vaporox, Inc. | 1 | $136 |
| Abbott | 2 | $119 |
| Stryker | 1 | $78 |
| Theramicro, Inc. | 1 | $57 |
| Organogenesis Inc. | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Smith+Nephew | 2 | $40 |
| Pfizer | 2 | $34 |
| Curonix LLC | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Amgen | 1 | $20 |
| Nevro Corp. | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Convatec Inc. | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$368,189
- Reference Toe System$1,000
- AlloAid Allograft$1,000
- Lapiplasty System$851
- VHT-200 Wound Treatment System$136
- AVYCAZ$126
How this compares
$383,636 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naftifine Hcl | 95 | $17,007 |
| Pregabalin | 119 | $4,058 |
| Ketoconazole | 173 | $3,818 |
| Mupirocin | 287 | $3,758 |
| Ammonium Lactate | 219 | $3,729 |
| Diclofenac Sodium ErDiclofenac Sodium | 93 | $1,847 |
| Diclofenac Sodium | 67 | $1,439 |
| CiclopiroxCiclopirox Olamine | 36 | $915 |
| Cephalexin | 115 | $626 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 92 | $610 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $480 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $214 |
| Tramadol Hcl | 35 | $117 |
| Gabapentin | 11 | $72 |
| Ibuprofen | 16 | $60 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houston
- Kevin VarnerHouston$1.1M
- Sherman NaglerHouston$602K
- Abdul NurudeenHouston$404K
- Brian LepowHouston$311K
- William GranberryHouston$155K
- Yueh LeeHouston$95K
- Julie LesterHouston$94K
- Jason AhueroHouston$76K
- Nathaniel AlabiHouston$71K
- Richard PollakSan Antonio$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.